Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer-Reference-Cited by-同舟云学术

Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer

Published:2011 Issue:1-2 Volume:80 Page:97-101
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Isayama Hiroyuki,Nakai Yousuke,Yamamoto Keisuke,Sasaki Takashi,Mizuno Suguru,Yagioka Hiroshi,Yashima Yoko,Kawakubo Kazumichi,Kogure Hirofumi,Arizumi Toshihiko,Togawa Osamu,Ito Yukiko,Matsubara Saburo,Yamamoto Natsuyo,Sasahira Naoki,Hirano Kenji,Tsujino Takeshi,Tada Minoru,Omata Masao,Koike Kazuhiko

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference29 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

2. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial

3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

4. Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial.

5. Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line;Biomedicines;2022-02-15

2. Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients;Cancer Chemotherapy and Pharmacology;2018-06-23

3. Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation;PLOS ONE;2016-10-20

4. Antitumor effects of herbal mixture extract in the pancreatic adenocarcinoma cell line PANC1;Oncology Reports;2016-09-05

5. Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites;Investigational New Drugs;2016-06-23